Sernova Biotherapeutics, Inc. (SVA.TO)
0.11
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
Sernova Biotherapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 34.02 |
| April 26, 2024 | 34.81 |
| April 25, 2024 | 33.62 |
| April 24, 2024 | 34.02 |
| April 23, 2024 | 35.21 |
| April 22, 2024 | 34.41 |
| April 19, 2024 | 35.60 |
| April 18, 2024 | 35.60 |
| April 17, 2024 | 36.79 |
| April 16, 2024 | 36.79 |
| April 15, 2024 | 37.18 |
| April 12, 2024 | 36.79 |
| April 11, 2024 | 41.14 |
| April 10, 2024 | 31.25 |
| April 09, 2024 | 32.83 |
| April 08, 2024 | 37.58 |
| April 05, 2024 | 39.56 |
| April 04, 2024 | 41.14 |
| April 03, 2024 | 41.93 |
| April 02, 2024 | 41.93 |
| April 01, 2024 | 45.89 |
| March 28, 2024 | 42.72 |
| March 27, 2024 | 44.30 |
| March 26, 2024 | 43.51 |
| March 25, 2024 | 43.51 |
| Date | Value |
|---|---|
| March 22, 2024 | 45.89 |
| March 21, 2024 | 44.30 |
| March 20, 2024 | 45.10 |
| March 19, 2024 | 45.10 |
| March 18, 2024 | 47.47 |
| March 15, 2024 | 47.47 |
| March 14, 2024 | 44.30 |
| March 13, 2024 | 45.10 |
| March 12, 2024 | 43.51 |
| March 11, 2024 | 42.72 |
| March 08, 2024 | 44.30 |
| March 07, 2024 | 43.51 |
| March 06, 2024 | 45.89 |
| March 05, 2024 | 47.47 |
| March 04, 2024 | 45.89 |
| March 01, 2024 | 47.47 |
| February 29, 2024 | 47.47 |
| February 28, 2024 | 47.47 |
| February 27, 2024 | 49.05 |
| February 26, 2024 | 50.63 |
| February 23, 2024 | 50.63 |
| February 22, 2024 | 51.42 |
| February 21, 2024 | 53.80 |
| February 20, 2024 | 53.80 |
| February 16, 2024 | 55.38 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Microbix Biosystems, Inc. | 1.807 |
| Helix BioPharma Corp. | 4.264 |
| Hemostemix, Inc. | -- |
| Medicenna Therapeutics Corp. | 23.44 |
| Spectral Medical, Inc. | -- |
Price to Book Value Related Metrics
| Price | 0.11 |
| Earnings Yield | -26.73% |
| Market Cap | 41.54M |